Lipid‐Polymer Nanoparticles Mediate Compartmentalized Delivery of Cas9 and sgRNA for Glioblastoma Vasculature and Immune Reprogramming
Advanced Science · 2024-08 · 11 (32)
DOI: 10.1002/advs.202309314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 23.06.2024. Verfasst von Huaqing Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing, 210009, China. Hauptthemen laut MEDLINE: Glioblastoma, Nanoparticles, Polymers. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Hypervascularized glioblastoma is naturally sensitive to anti‐angiogenesis but suffers from low efficacy of transient vasculature normalization. In this study, a lipid‐polymer nanoparticle is synthesized to execute compartmentalized Cas9 and sgRNA delivery for a permanent vasculature editing strategy by knocking out the signal transducer and activator of transcription 3 (STAT3). The phenylboronic acid branched cationic polymer is designed to condense sgRNA electrostatically (inner compartment) and patch Cas9 coordinatively (outer compartment), followed by liposomal hybridization with angiopep‐2 decoration for blood–brain barrier (BBB) penetration. The lipid‐polymer nanoparticles can reach glioblastoma within 2 h post intravenous administration, and hypoxia in tumor cells triggers charge‐elimination and degradation of the cationic polymer for burst release of Cas9 and sgRNA, accompanied by instant Cas9 RNP assembly, yielding ≈50% STAT3 knockout. The downregulation of downstream vascular endothelial growth factor (VEGF) reprograms vasculature normalization to improve immune infiltration, collaborating with interleukin‐6 (IL‐6) and interleukin‐10 (IL‐10) reduction to develop anti‐glioblastoma responses. Collectively, the combinational assembly for compartmentalized Cas9/sgRNA delivery provides a potential solution in glioblastoma therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing, 210009, China.
- State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China.
ORCID-Profile: Yang Ding
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Fundamental Research Funds for the Central Universities
- National Ten Thousand Talents Program for Young Top-notch Talents
- Young Talent Support Project of Jiangsu Association for Science and Technology
- Jiangsu 333 High-level Talent Training Project
- Double First-Rate Construction Plan of China Pharmaceutical University
- Project of the State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University
Zitieren
APA
Zhang, H., Jiang, W., Song, T., Song, M., Liu, S., Zhou, J., Cheng, H., & Ding, Y. (2024). Lipid‐Polymer Nanoparticles Mediate Compartmentalized Delivery of Cas9 and sgRNA for Glioblastoma Vasculature and Immune Reprogramming. Advanced Science, 11(32). https://doi.org/10.1002/advs.202309314
Vancouver
Zhang H, Jiang W, Song T, Song M, Liu S, Zhou J, et al. Lipid‐Polymer Nanoparticles Mediate Compartmentalized Delivery of Cas9 and sgRNA for Glioblastoma Vasculature and Immune Reprogramming. Advanced Science. 2024;11(32). doi:10.1002/advs.202309314
BibTeX
@article{Zhang2024,
author = {Zhang, Huaqing and Jiang, Wenxin and Song, Tingting and Song, Mingjie and Liu, Shengyu and Zhou, Jianping and Cheng, Hao and Ding, Yang},
title = {Lipid‐Polymer Nanoparticles Mediate Compartmentalized Delivery of Cas9 and sgRNA for Glioblastoma Vasculature and Immune Reprogramming},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {32},
doi = {10.1002/advs.202309314}
}
EUVIMED